Douglas Carr
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Douglas Carr
Douglas Carr is recorded as CFO at Century Therapeutics, Inc. (IPSC). Century Therapeutics, Inc. reported in an 8-K filed July 7, 2025 that Douglas Carr was appointed interim Principal Financial Officer, effective July 11, 2025.
“Following the effectiveness of Dr. Conn's departure from the Company, Douglas Carr, the Company's Senior Vice President, Finance, will serve as interim Principal Financial Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-07-11–present
-
Century Therapeutics, Inc. (IPSC)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Century Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Brent Pfeiffenberger CEO, Chairman
- Gregory Russotti, Ph.D. CEO
- Brent Pfeiffenberger, Pharm.D. Chairman
- Michael Diem CFO
- Morgan Conn, Ph.D. CFO
- Gregory Russotti CTO
- Alessandro Riva Board Member
- Dr. Han Lee Board Member
- Dr. Martin Murphy Board Member
- Han Lee Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.